Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen

被引:38
作者
Wu, HC [1 ]
Jung, MY
Chiu, CY
Chao, TT
Lai, SC
Jan, JT
Shaio, MF
机构
[1] Natl Taiwan Univ, Coll Med, Grad Inst Oral Biol, Taipei 100, Taiwan
[2] Natl Def Med Ctr, Inst Prevent Med, Taipei 100, Taiwan
关键词
D O I
10.1099/vir.0.19228-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In this study, a serotype-specific monoclonal antibody (mAb), D-2 16-1 (Ab4), against dengue virus type 2 (DEN-2) was generated. The specificity of Ab4, which recognized DEN-2 non-structural protein 1, was determined by ELISA, immunofluorescence and immunoblotting analyses. The serotype-specific B-cell epitope of Ab4 was identified further from a random phage-displayed peptide library; selected phage clones reacted specifically with Ab4 and did not react with other mAbs. Immunopositive phage clones displayed a consensus motif, His-Arg/Lys-Leu/Ile, and a synthetic peptide corresponding to the phage-displayed peptide bound specifically to Ab4. The His and Arg residues in this epitope were found to be crucial for peptide binding to Ab4 and binding activity decreased dramatically when these residues were changed to Leu. The epitope-based synthetic peptide not only identified serum samples from DEN-2-immunized mice and rabbits by ELISA but also differentiated clearly between serum samples from DEN-2- and Japanese encephalitis virus-immunized mice. This mAb and its epitope-based peptide antigen will be useful for serologic diagnosis of DEN-2 infection. Furthermore, DEN-2 epitope identification makes it feasible to dissect antibody responses to DEN and to address the role of antibodies in the pathogenesis of primary and secondary DEN-2 infections.
引用
收藏
页码:2771 / 2779
页数:9
相关论文
共 55 条
[1]   SEROLOGICALLY DEFINED LINEAR EPITOPES IN THE ENVELOPE PROTEIN OF DENGUE-2 (JAMAICA STRAIN 1409) [J].
AASKOV, JG ;
GEYSEN, HM ;
MASON, TJ .
ARCHIVES OF VIROLOGY, 1989, 105 (3-4) :209-221
[2]   AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1 [J].
Akeson, AL ;
Woods, CW ;
Hsieh, LC ;
Bohnke, RA ;
Ackermann, BL ;
Chan, KY ;
Robinson, JL ;
Yanofsky, SD ;
Jacobs, JW ;
Barrett, RW ;
Bowlin, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30517-30523
[3]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[4]   Targeting the prostate for destruction through a vascular address [J].
Arap, W ;
Haedicke, W ;
Bernasconi, M ;
Kain, R ;
Rajotte, D ;
Krajewski, S ;
Ellerby, HM ;
Bredesen, DE ;
Pasqualini, R ;
Ruoslahti, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1527-1531
[5]   Structural plasticity in a remodeled protein-protein interface [J].
Atwell, S ;
Ultsch, M ;
DeVos, AM ;
Wells, JA .
SCIENCE, 1997, 278 (5340) :1125-1128
[6]   CONTINUOUS AND DISCONTINUOUS PROTEIN ANTIGENIC DETERMINANTS [J].
BARLOW, DJ ;
EDWARDS, MS ;
THORNTON, JM .
NATURE, 1986, 322 (6081) :747-748
[7]   Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries [J].
Barry, MA ;
Dower, WJ ;
Johnston, SA .
NATURE MEDICINE, 1996, 2 (03) :299-305
[8]   Pathogenesis of dengue virus diseases: missing pieces in the jigsaw [J].
BielefeldtOhmann, H .
TRENDS IN MICROBIOLOGY, 1997, 5 (10) :409-413
[9]   Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].
Bottger, A ;
Bottger, V ;
Sparks, A ;
Liu, WL ;
Howard, SF ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (11) :860-869
[10]  
Bottger V, 1996, ONCOGENE, V13, P2141